Cargando…

Editorial for targets and anticancer drug research

Detalles Bibliográficos
Autor principal:	.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237752/ https://www.ncbi.nlm.nih.gov/pubmed/28119803 http://dx.doi.org/10.1016/j.apsb.2016.12.004

Ejemplares similares

Editorial: RNA recognition landscapes and anticancer drug targeting
por: Salvati, Erica, et al.
Publicado: (2023)

Editorial: Network-Oriented Approaches to Anticancer Drug Response
por: Lecca, Paola, et al.
Publicado: (2021)

Editor Profile: Guest Editor of Special Issue on Targets and Anticancer Drug Research
por: Fu, Liwu
Publicado: (2017)

Editorial on Anticancer Antioxidants
por: Sunjic, Suzana Borovic, et al.
Publicado: (2021)

Targeted Delivery Methods for Anticancer Drugs
por: Veselov, Valery V., et al.
Publicado: (2022)

Editorial: Recent advances in the research and development of kinase-inhibitory anticancer molecules
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2023)

The ubiquitin-proteasome system: A novel target for anticancer and anti-inflammatory drug research
por: Ostrowska, Halina
Publicado: (2008)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

Cannabinoids as anticancer drugs: current status of preclinical research
por: Hinz, Burkhard, et al.
Publicado: (2022)

Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2
por: Asai, Ayumu, et al.
Publicado: (2018)

Editorial: Antimicrobial and Anticancer Peptides
por: O'Brien-Simpson, Neil M., et al.
Publicado: (2018)

Anticancer drug discovery by targeting cullin neddylation
por: Yu, Qing, et al.
Publicado: (2020)

Chromatin as a Target for the DNA-Binding Anticancer Drugs
por: Majumder, Parijat, et al.
Publicado: (2007)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
por: Heudobler, Daniel, et al.
Publicado: (2021)

Editorial: Antimicrobials and Anticancers of Bacterial Origins
por: Freitas, Ana R., et al.
Publicado: (2020)

Editorial: Anticancer Potential of Artemisia annua
por: Kolesar, Jill M., et al.
Publicado: (2022)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Research Progress and Prospects for Polymeric Nanovesicles in Anticancer Drug Delivery
por: Li, Dan, et al.
Publicado: (2022)

NSAIDs: Old Drugs Reveal New Anticancer Targets
por: Piazza, Gary A., et al.
Publicado: (2010)

Targeting anticancer drug-induced senescence in glioblastoma therapy
por: Tomicic, Maja T., et al.
Publicado: (2018)

MicroRNA as an Important Target for Anticancer Drug Development
por: Fu, Zhiwen, et al.
Publicado: (2021)

Progestins as Anticancer Drugs and Chemosensitizers, New Targets and Applications
por: Fedotcheva, Tatiana A., et al.
Publicado: (2021)

Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer Drugs
por: Bauer, Martin, et al.
Publicado: (2020)

Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies
por: Ng, Chau Yee, et al.
Publicado: (2018)

The Anticancer Drugs
por: Wilkinson, P.
Publicado: (1980)

Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles
por: Rodzinski, Alexandra, et al.
Publicado: (2016)

Peptide-Mediated Targeted Delivery of Aloe-Emodin as Anticancer Drug
por: Stringaro, Annarita, et al.
Publicado: (2022)

Cdt1 Is Differentially Targeted for Degradation by Anticancer Chemotherapeutic Drugs
por: Stathopoulou, Athanasia, et al.
Publicado: (2012)

Novel application of metformin combined with targeted drugs on anticancer treatment
por: Deng, Jun, et al.
Publicado: (2018)

Editorial: Small organic molecules with anticancer activity
por: Rahman, A. F. M. Motiur, et al.
Publicado: (2023)

Clinical anticancer drug development: targeting the cyclin-dependent kinases
por: Benson, C, et al.
Publicado: (2005)

Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug
por: Wang, Hao, et al.
Publicado: (2014)

DNA-Binding Anticancer Drugs: One Target, Two Actions
por: Baguley, Bruce C., et al.
Publicado: (2021)

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery
por: Tang, Lu, et al.
Publicado: (2021)

GT198 Is a Target of Oncology Drugs and Anticancer Herbs
por: Pang, Junfeng, et al.
Publicado: (2021)

Setting molecular traps in yeast for identification of anticancer drug targets
por: Brown, Grant W., et al.
Publicado: (2021)

Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors
por: Li, Qianqian, et al.
Publicado: (2022)

Small molecules targeting Pin1 as potent anticancer drugs
por: Zhang, Jing, et al.
Publicado: (2023)

Targeting TRIP13 for overcoming anticancer drug resistance (Review)
por: Zhao, Liwen, et al.
Publicado: (2023)

Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein
por: Nabekura, Tomohiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ubcrlbqk3f842qaejs4b5t5j1h